Financial Enhancement Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-7
Closed – – 333
2022
Q2
$0 Hold
7
– – ﹤0.01% 330
2022
Q1
$1K Hold
7
– – ﹤0.01% 298
2021
Q4
$1K Hold
7
– – ﹤0.01% 265
2021
Q3
$1K Hold
7
– – ﹤0.01% 267
2021
Q2
$1K Sell
7
-4
-36% -$648 ﹤0.01% 265
2021
Q1
$2K Buy
+11
New +$2.55K ﹤0.01% 247
2020
Q2
– Sell
-6,023
Closed -$934K – 304
2020
Q1
$934K Sell
6,023
-15,339
-72% -$1.78M 0.28% 49
2019
Q4
$1.79M Buy
+21,362
New +$1.63M 0.45% 38

Other funds holding TDOC

Financial Enhancement Group's TDOC Position: Q3 2022 in Review

Financial Enhancement Group sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 7 shares.

Financial Enhancement Group first reported a position in TDOC in Q4 2019 and held it in 8 quarters. The position peaked at $1.79M in Q4 2019. 483 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Financial Enhancement Group reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • Financial Enhancement Group sold 7 Teladoc Health shares in Q3 2022.
  • Financial Enhancement Group first reported a position in Teladoc Health in Q4 2019 and held it in 8 quarters.
  • Financial Enhancement Group's Teladoc Health position peaked at $1.79M in Q4 2019.
  • 483 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Financial Enhancement Group's 13F filing for Q3 2022, filed 27 Oct 2022.